For the Inventor, By the Inventor

Enter assignee name

Alpharetta, GA, United States of America

Inhibitex, Inc.

USPTO Granted Patents = 16

% Expired Patents = 25.0

CIPO Patents = 2

EPO Patents = 5

Forward Citations = 262

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

Joseph M Patti (13 out of 27 patents)

Jeff T Hutchins (9 out of 9 patents)

Magnus A Hook (7 out of 25 patents)

4. Andrea Hall (6 out of 6 patents)

5. Timothy James Foster (6 out of 24 patents)

6. Paul Domanski (4 out of 4 patents)

7. Pietro Speziale (3 out of 6 patents)

8. Yi Xu (3 out of 8 patents)

9. Maria G Bowden (3 out of 3 patents)

10. Pratiksha Patel (3 out of 3 patents)

11. John Vernachio (2 out of 4 patents)

12. Karolina Madela (2 out of 2 patents)

13. Fiona Roche (2 out of 2 patents)

14. Mark Pallen (2 out of 2 patents)

15. Jouko V Sillanpaa (2 out of 2 patents)

16 patents: Sort by Forward Citations

1. 9351989 - Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections (2016-05-31),

2. 9296795 - Polysaccharide-staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections (2016-03-29),

3. 8759318 - Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections (2014-06-24),

4. 8475798 - [object Object] (2013-07-02),

5. 8017133 - Multicomponent vaccines (2011-09-13),

6. 7968100 - [object Object] (2011-06-28),

7. 7850974 - Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby (2010-12-14),

8. 7666438 - Multicomponent vaccines (2010-02-23),

9. 7615616 - Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby (2009-11-10),

10. 7381793 - [object Object] (2008-06-03),

11. 7364738 - Monoclonal antibodies to the CLFA protein and method of use in treating infections (2008-04-29),

12. 7241592 - Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use (2007-07-10),

13. 7115264 - Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections (2006-10-03),

14. 7045131 - Staphylococcal immunotherapeutics via donor selection and donor stimulation (2006-05-16),

15. 6979446 - Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections (2005-12-27),

Inhibitex, Inc. is a pharmaceutical company specializing in the discovery and development of innovative antiviral compounds. With a focus on treating infectious diseases, particularly those caused by a range of viruses, Inhibitex aims to offer effective and safe treatment options for patients. The company conducts rigorous research and clinical trials to advance its pipeline of novel antiviral drugs. Inhibitex is committed to improving public health and delivering innovative solutions to combat viral infections.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

16 Patents

#41 in Alpharetta, GA

#377 in Georgia

#19,887 in US

#37,739 in the World

Alpharetta, GA, United States of America

Inhibitex, Inc.

Forward Citations = 262

35 inventors:

Joseph M Patti (13 out of 27 patents)

Jeff T Hutchins (9 out of 9 patents)

Magnus A Hook (7 out of 25 patents)

4. Andrea Hall (6 out of 6 patents)

5. Timothy James Foster (6 out of 24 patents)

Please report any incorrect information to [email protected]

Loading…